Quick Answer
HOOKIPA Pharma Inc. reported Total Revenue of $43.95 million for fiscal year 2024.
HOOKIPA Pharma Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $43.95M | +118.3% |
| 2023 | $20.13M | +41.3% |
| 2022 | $14.25M | -22.8% |
| 2021 | $18.45M | -5.8% |
| 2020 | $19.58M | +64.0% |
| 2019 | $11.94M | +56.5% |
| 2018 | $7.63M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $2.00M | -94.5% | -57.4% |
| September 30, 2024 | $4.70M | -31.5% | +264.6% |
| June 30, 2024 | $1.29M | -51.8% | -96.5% |
| March 31, 2024 | $36.60M | +1052.4% | +433.0% |
| September 30, 2023 | $6.87M | +207.9% | +156.3% |
| June 30, 2023 | $2.68M | -2.4% | -15.6% |
| March 31, 2023 | $3.18M | +119.8% | +42.4% |
| September 30, 2022 | $2.23M | -42.4% | -18.8% |
- HOOKIPA Pharma Inc. showed an increase of +118.3% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2024 period, HOOKIPA Pharma Inc.’s total revenue has grown by 476.0% (from $7.63 million to $43.95 million).
- The most recent figure is from HOOKIPA Pharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: